4.8 Article

The miR-99 family regulates the DNA damage response through its target SNF2H

Journal

ONCOGENE
Volume 32, Issue 9, Pages 1164-1172

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2012.131

Keywords

microRNA; DNA repair; cancer; SNF2H; miR-99

Funding

  1. DOD BCRP predoctoral traineeship [BC073568]
  2. DOD PCRP predoctoral traineeship [PC094499]
  3. [P01CA104106]
  4. CDMRP [546578, PC094499] Funding Source: Federal RePORTER

Ask authors/readers for more resources

Chromatin remodeling factors are becoming known as crucial facilitators of recruitment of repair proteins to sites of DNA damage. Multiple chromatin remodeling protein complexes are now known to be required for efficient double strand break repair. In a screen for microRNAs (miRNAs) that modulate the DNA damage response, we discovered that expression of the miR-99 family of miRNAs correlates with radiation sensitivity. These miRNAs were also transiently induced following radiation. The nniRNAs target the SWI/SNF chromatin remodeling factor SNF2H/SMARCA5, a component of the ACF1 complex. We found that by reducing levels of SNF2H, miR-99a and miR-100 reduced BRCA1 localization to sites of DNA damage. Introduction of the miR-99 family of miRNAs into cells reduced the rate and overall efficiency of repair by both homologous recombination and non-homologous end joining. Finally, induction of the miR-99 family following radiation prevents an increase in SNF2H expression and reduces the recruitment of BRCA1 to the sites of DNA damage following a second dose of radiation, reducing the efficiency of repair after multiple rounds of radiation, as used in fractionated radiotherapy. Oncogene (2013) 32, 1164-1172; doi:10.1038/onc.2012.131; published online 23 April 2012

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide

Ayman J. Oweida, Adam C. Mueller, Miles Piper, Dallin Milner, Benjamin Van Court, Shilpa Bhatia, Andy Phan, Thomas Bickett, Kimberly Jordan, Theresa Proia, Richard Schulick, Wells A. Messersmith, Marco Del Chiaro, Eric Clambey, Michael J. Gough, Jason Williams, Kirk Hansen, Karyn Goodman, Sana D. Karam

Summary: Pancreatic ductal adenocarcinoma (PDAC) has a heterogeneous tumor microenvironment, and targeting STAT3 in combination with RT can mitigate the pro-tumorigenic effects of RT and improve tumor response by reducing RT-induced MDSC infiltration and increasing effector T cell proportion.STAT3 inhibition also contributes to the remodeling of the PDAC extracellular matrix when combined with RT, resulting in decreased collagen deposition and fibrotic tissue formation. Overall, the study provides evidence that targeting STAT3 in combination with RT is a promising approach to enhance the anti-tumor effects of radiotherapy in PDAC.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Gastroenterology & Hepatology

Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer

Sara J. Zakem, Adam C. Mueller, Cheryl Meguid, Robert J. Torphy, Douglas E. Holt, Tracey Schefter, Wells A. Messersmith, Martin D. McCarter, Marco Del Chiaro, Richard D. Schulick, Karyn A. Goodman

Summary: In patients with BRPC and LAPC undergoing neoadjuvant chemotherapy and SBRT, promising pathologic response rates, R0 resection rates, and acceptable perioperative morbidity were observed.
Article Cell Biology

Chk1 promotes non-homologous end joining in G1 through direct phosphorylation of ASF1A

Kyung Yong Lee, Anindya Dutta

Summary: The cell-cycle phase plays a crucial role in determining repair pathway choice at DNA double-strand breaks, with Chk1 promoting non-homologous end joining (NHEJ) repair in the G1 phase. ASF1A, a histone chaperone, also promotes NHEJ independently of its chaperone activity. Chk1 phosphorylates ASF1A at Ser-166 in G1, enhancing its interaction with the repair protein MDC1 and promoting NHEJ repair.

CELL REPORTS (2021)

Article Oncology

Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

Adam C. Mueller, Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia, Andy Phan, Benjamin Van Court, Kathryn L. Zolman, Brisa Pena, Ayman J. Oweida, Sara Zakem, Cheryl Meguid, Michael W. Knitz, Laurel Darragh, Thomas E. Bickett, Jacob Gadwa, Luisa Mestroni, Matthew R. G. Taylor, Kimberly R. Jordan, Peter Dempsey, M. Scott Lucia, Martin D. McCarter, Marco Del Chiaro, Wells A. Messersmith, Richard D. Schulick, Karyn A. Goodman, Michael J. Gough, Casey S. Greene, James C. Costello, Antonio Galveo Neto, David Lagares, Kirk C. Hansen, Adrie Van Bokhoven, Sana D. Karam

Summary: This study identified drivers of fibrosis and tumor progression in PDAC tumors after radiation therapy, and proposed a targetable pathway to enhance radiation therapy efficacy.

CANCER RESEARCH (2021)

Article Multidisciplinary Sciences

Germline variants predictive of tumor mutational burden and immune checkpoint inhibitor efficacy

Ajay Chatrath, Aakrosh Ratan, Anindya Dutta

Summary: High TMB is associated with response to checkpoint blockade in cancer, and germline variants (GVITMB) in certain genes are found to influence molecular phenotypes of tumors and predict the response to immune checkpoint inhibitors.

ISCIENCE (2021)

Editorial Material Multidisciplinary Sciences

De-stressing the T cells in need Protection of transfer RNAs from fragmentation avoids overstressing T cells

Zhangli Su, Anindya Dutta

SCIENCE (2021)

Review Oncology

Systematic review and meta-analysis of radiation therapy for high-risk non-muscle invasive bladder cancer

Rodrigo Rodrigues Pessoa, Adam C. Mueller, Peter Boxley, Thomas W. Flaig, Christi Piper, Badrinath Konety, James B. Yu, Boris Gershman, Janet Kukreja, Simon P. Kim

Summary: XRT for high-risk NMIBC provides some degree of oncologic control, although distant progression was noted. In the setting of the low-quality evidence, a prospective clinical trial is needed to clearly define the risks and benefits of this approach.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Article Oncology

Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis

Michael W. Knitz, Thomas E. Bickett, Laurel B. Darragh, Ayman J. Oweida, Shilpa Bhatia, Benjamin Van Court, Shiv Bhuvane, Miles Piper, Jacob Gadwa, Adam C. Mueller, Diemmy Nguyen, Varuna Nangia, Douglas G. Osborne, Xiyuan Bai, Sarah E. Ferrara, Mary-Keara Boss, Andrew Goodspeed, Matthew A. Burchill, Beth A. Jiron Tamburini, Edward D. Chan, Curtis R. Pickering, Eric T. Clambey, Sana D. Karam

Summary: The study reveals that regulating Treg functionality and DC activation status is crucial for generating a T cell effector response in highly radioresistant HNSCC tumors. The findings suggest a new therapeutic approach for reprogramming the tumor microenvironment in HNSCCs resistant to conventional radioimmunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma

Miles Piper, Benjamin Van Court, Adam Mueller, Shuichi Watanabe, Thomas Bickett, Shilpa Bhatia, Laurel B. Darragh, Max Mayeda, Diemmy Nguyen, Jacob Gadwa, Michael Knitz, Sophia Corbo, Rustain Morgan, Jung-Jae Lee, Alexander Dent, Karyn Goodman, Wells Messersmith, Richard Schulick, Marco Del Chiaro, Yuwen Zhu, Ross M. Kedl, Laurel Lenz, Sana D. Karam

Summary: The study found that radiotherapy increases the infiltration and activation of dendritic cells in pancreatic ductal adenocarcinoma (PDAC) patients, but also increases the infiltration of Treg cells while failing to recruit NK cells and CD8 T cells. Targeting Treg-mediated immunosuppression with STAT3 inhibition improves disease control and enhances NK cell-mediated immune surveillance of metastasis. Targeting Treg-mediated immunosuppression is a critical step in improving treatment response.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

HPVE6-USP46 Mediated Cdt2 Stabilization Reduces Set8 Mediated H4K20-Methylation to Induce Gene Expression Changes

Shashi Kiran, Briana Wilson, Shekhar Saha, Julia Ann Graff, Anindya Dutta

Summary: This study revealed that the E6-USP46 complex in cervical cancer increases Cdt2 levels and decreases Set8 levels, promoting cancer progression, and suggests USP46 as a potential drug target for HPV-induced cancers.

CANCERS (2022)

Article Multidisciplinary Sciences

TRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer

Zhangli Su, Ida Monshaugen, Briana Wilson, Fengbin Wang, Arne Klungland, Rune Ougland, Anindya Dutta

Summary: This study reveals the presence of N-1-methyladenosine modification in small RNAs, which acts as a regulatory element in gene expression. The higher level of m(1)A modification in bladder cancer is associated with dysregulation of genes involved in unfolded protein response.

NATURE COMMUNICATIONS (2022)

Review Immunology

The poorly immunogenic tumor microenvironment of pancreatic cancer: the impact of radiation therapy, and strategies targeting resistance

Robert Hughes, Adam E. Snook, Adam C. Mueller

Summary: Pancreatic cancer is a highly aggressive and therapy-resistant cancer with an immunosuppressive tumor microenvironment. Previous attempts at utilizing immunotherapies have been unsuccessful in treating pancreatic cancer. Unlike other cancers, radiation therapy has limited success in stimulating immune responses in pancreatic cancer due to the common pathways of fibrosis and chronic inflammation activated by radiation therapy, resulting in immune suppression. Targeting these pathways may improve outcomes by utilizing the cytotoxic and immune-activating aspects of radiation therapy.

IMMUNOTHERAPY (2022)

Article Genetics & Heredity

XRN2 suppresses aberrant entry of tRNA trailers into argonaute in humans and Arabidopsis

Briana A. Wilson, Zhangli Su, Pankaj A. Kumar, Anindya A. Dutta

Summary: Gene expression is regulated by small RNAs binding to mRNAs within RISC, reducing protein production. Some tRFs are able to interact with RISC, but the mechanism for selective entry is unclear. We provide evidence that tRF-1s have short half-lives mediated by XRN2 degradation, preventing their accumulation in RISC. Our study highlights the complex and tightly controlled nature of RISC, with implications for tRF and microRNA biology.

PLOS GENETICS (2023)

Article Biochemical Research Methods

Integrated bioinformatic pipeline using whole-exome and RNAseq data to identify germline variants correlated with cancer

Divya Sahu, Ajay Chatrath, Aakrosh Ratan, Anindya Dutta

Summary: Here, a bioinformatic pipeline is presented to identify germline variants (GVs) in the TCGA lower grade glioma cohort and predict cancer risk and patient outcomes. By integrating paired whole exome sequences and tumor RNA sequences, a patient's GV status can be determined, and a subset of predictive GVs can be identified using Cox regression.

STAR PROTOCOLS (2022)

Article Oncology

Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer

Rustain L. Morgan, Megan M. Eguchi, Jessica McDermott, Adam C. Mueller, Arya Amini, Julie A. Goddard, Premal S. Trivedi, Sana D. Karam

Summary: The study found that posttreatment imaging with PET was associated with improved survival in patients with advanced laryngeal carcinoma compared to CT imaging. There was a trend towards improved cancer-specific survival in patients with oral cavity or oropharyngeal malignancies who underwent PET/CT imaging, but it did not reach statistical significance.

CANCER (2021)

No Data Available